Related Experiment Videos

Leukocyte activation and phagocytotic activity in cardiac surgery and infection

Markus Rothenburger1, Frank Trösch, Andreas Markewitz

  • 1Department of Thoracic and Cardiovascular Surgery, University Hospital of Muenster, Albert-Schweitzer Str. 33, Germany. markus.rothenburger@thgms.uni-muenster.de

Cardiovascular Surgery (London, England)
|October 16, 2002
PubMed

Insights

Cardiac surgery (CS) with cardiopulmonary bypass (CPB) triggers leukocyte activation and systemic inflammatory response. Immune response remains adequate, but caution is advised for leukocyte depletion therapies.

Area of Science:

  • Cardiovascular Surgery
  • Immunology
  • Critical Care Medicine

Background:

  • Cardiac surgery (CS) utilizing cardiopulmonary bypass (CPB) can induce a systemic inflammatory response syndrome.
  • Leukocyte activation is a key mechanism contributing to this inflammatory response, potentially exacerbated by concurrent infections.

Purpose of the Study:

  • To investigate leukocyte activation and reticuloendothelial system (RES) function in patients undergoing CS with CPB.
  • To compare immune markers between patients with uneventful recovery and those who develop systemic infections.

Main Methods:

  • Prospective study of 85 patients undergoing CS with CPB.
  • Measurement of leukocyte counts, elastase levels, and phagocytotic activity preoperatively and up to 7 days postoperatively.
  • Categorization of patients into uneventful course (n=79) and systemic infection (n=6) groups.

Main Results:

  • Leukocyte and elastase levels increased postoperatively, with significantly higher levels in the infection group (p<0.01).
  • A decrease in the leukocyte/elastase ratio was observed in all patients (p<0.002), with no intergroup differences.
  • Phagocytotic activity initially dropped on day 1 (p<0.05) but increased above baseline (p<0.001), with no significant differences between groups.

Conclusions:

  • Leukocyte activation is a common finding after CS with CPB, associated with normal RES function and adequate immune response.
  • Therapeutic strategies aimed at leukocyte depletion to mitigate reperfusion injury require caution, as they may compromise immune response in infected patients.
  • Leukocyte depletion might benefit patients requiring prolonged CPB, warranting further investigation.
Abstract

Related Concept Videos